Related Experiment Videos
Surgical implications of antithrombin III deficiency
Surgery
|April 1, 1981
Summary
Congenital antithrombin III deficiency increases thrombosis risk, complicating surgery. Effective management involves fresh frozen plasma and warfarin therapy to prevent further clotting events.
Area of Science:
- Hematology
- Vascular Medicine
- Genetics
Background:
- Antithrombin III is a key plasma inhibitor of coagulation.
- Congenital antithrombin III deficiency is linked to thrombotic risks and surgical complications.
Observation:
- A patient with congenital antithrombin III deficiency experienced superior mesenteric vein thrombosis.
- This event occurred after discontinuing warfarin therapy, leading to small intestine venous gangrene.
Findings:
- The patient's condition was initially treated with fresh frozen plasma.
- Long-term warfarin therapy proved effective in preventing recurrent thrombotic events.
Implications:
- This case highlights the critical role of antithrombin III in preventing thrombosis.
- Appropriate anticoagulation management is essential for patients with antithrombin III deficiency.
- Early intervention and sustained therapy can mitigate severe complications like mesenteric venous thrombosis.